SEC Form D · filed June 17, 2021
Cyclerion Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (30)
Cheryl M. Gault · Cambridge, MAExecOle M. Isacson · Cambridge, MADirectorPeter M. Hecht · Cambridge, MAExec · DirectorTerrance M. Mcguire · Cambridge, MADirectorAnjeza M. Gjino · Cambridge, MAExecErrol M. De Souza · Cambridge, MADirectorStephanie M. Lovell · Cambridge, MADirectorKevin M. Churchwell · Cambridge, MADirectorGeorge M. Conrades · Cambridge, MADirectorMichael M. Mendelsohn · Cambridge, MADirectorMarsha M. Fanucci · Cambridge, MADirectorJonathan C. Lieber · Houston, TXDirectorNichole Wischoff · Nashville, TNDirectorLeo Hathaway · Vancouver, British Columbia, CanadaDirectorPaul C. Lammers · Houston, TXExecJohn Youle · Vancouver, British Columbia, CanadaExec · DirectorDavid Farrell · Vancouver, British Columbia, CanadaExecAndreas M. Busch · Cambridge, MAExecFrederick W. Shaw · Conshohocken, PADirectorChris Fortson · Tampa, FLExec · DirectorKaran Arakotaram · Tampa, FLExecBrandon Jordan · New York, NYDirectorSylvia Brindis · New York, NYExecBob Kelly · New York, NYDirectorStephanie M. Lovell · Cambridge, MADirectorKevin M. Churchwell · Cambridge, MADirectorGeorge M. Conrades · Cambridge, MADirectorMichael M. Mendelsohn · Cambridge, MADirectorMarsha M. Fanucci · Cambridge, MADirectorAndreas M. Busch · Cambridge, MAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗